HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer von ROSES, Robert E, PAULSON, E. Carter, SHARMA, Anupama, SCHUELLER, Jeanne E, NISENBAUM, Harvey, WEINSTEIN, Susan, FOX, Kevin R, ZHANG, Paul J, CZERNIECKI, Brian J

Volltext

Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial von Lowenfeld, Lea, Mick, Rosemarie, Datta, Jashodeep, Xu, Shuwen, Fitzpatrick, Elizabeth, Fisher, Carla S., Fox, Kevin R., DeMichele, Angela, Zhang, Paul J., Weinstein, Susan P., Roses, Robert E., Czerniecki, Brian J.

Volltext

Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer von Clark, Amy S, McAndrew, Nicholas P, Troxel, Andrea, Feldman, Michael, Lal, Priti, Rosen, Mark, Burrell, Jessica, Redlinger, Colleen, Gallagher, Maryann, Bradbury, Angela R, Domchek, Susan M, Fox, Kevin R, O'Dwyer, Peter J, DeMichele, Angela M

Volltext

A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer von Frazier, Thomas G, Fox, Kevin R, Smith, J Stanley, Laronga, Christine, McSwain, Anita, Paul, Devchand, Schultz, Michael, Stilwill, Joseph, Teal, Christine, Weisberg, Tracey, Vacchino, Judith F, Sing, Amy P, Cherepanov, Dasha, Hsiao, Wendy, Chang, Eunice, Broder, Michael S

Volltext

Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer? von Pomponio, Maria K., Keele, Luke J., Fox, Kevin R., Clark, Amy S., Matro, Jennifer M., Shulman, Lawrence N., Tchou, Julia C.

Volltext

Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience von Pomponio, Maria K., Burkbauer, Laura, Goldbach, Macy, Nazarian, Susanna M., Xie, Fei, Clark, Amy S., Matro, Jennifer M., Fox, Kevin R., Shulman, Lawrence N., Keele, Luke J., Tchou, Julia

Volltext

Differences in Breast Cancer Survival by Race—Reply von Silber, Jeffrey H, Rosenbaum, Paul R, Fox, Kevin R

Volltext

Techniques for fertility preservation in patients with breast cancer von Dunn, Lara, Fox, Kevin R

Volltext

Skin‐sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high‐risk breast carcinoma von Downes, Kevin J., Glatt, Brian S., Kanchwala, Suhail K., Mick, Rosemarie, Fraker, Douglas L., Fox, Kevin R., Solin, Lawrence J., Bucky, Louis P., Czerniecki, Brian J.

Volltext

The impact of a multidisciplinary breast cancer center on recommendations for patient management: The University of Pennsylvania Experience von CHANG, John H, VINES, Eugenio, FOX, Kevin R, ZIEBER, Nancy, GLICK, John H, SOLIN, Lawrence J, BERTSCH, Helaine, FRAKER, Douglas L, CZERNIECKI, Brian J, ROSATO, Ernest F, LAWTON, Thomas, CONANT, Emily F, OREL, Susan G, SCHUCHTER, Lynn

Volltext

Adding Zoledronic Acid to Endocrine Therapy in the Adjuvant Treatment of Hormone-Sensitive Breast Cancer in Premenopausal Women: A New Care Standard or a Provocative Idea? von Fox, Kevin R.

Volltext

Micrometastases in Axillary Sentinel Lymph Nodes: How Significant are They? von Fox, Kevin R.

Volltext

Prescribing adjuvant letrozole to patients well after the completion of tamoxifen: a good idea? von Fox, Kevin R

Volltext

Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer von Fox, Kevin R.

Volltext

Optimizing outcomes with bevacizumab by better targeting patients and tumors von DeMichele, Angela, Fox, Kevin R

Volltext

The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy von Markiewicz, Deborah A., Schultz, Delray J., Haas, Jonathan A., Harris, Eleanor E.R., Fox, Kevin R., Glick, John H., Solin, Lawrence J.

Volltext

Does time to adjuvant chemotherapy von Keele, Luke J, Matro, Jennifer M, Fox, Kevin R, Clark, Amy S, Shulman, Lawrence N, Tchou, Julia C, Pomponio, Maria K

Volltext

Integrating Oncology Massage Into Chemoinfusion Suites: A Program Evaluation von Mao, Jun J, Wagner, Karen E, Seluzicki, Christina M, Hugo, Audra, Galindez, Laura K, Sheaffer, Heather, Fox, Kevin R

Volltext

Hypereosinophilia associated with cardiac rhabdomyosarcoma von Lo Re, Vincent, Fox, Kevin R., Ferrari, Victor A., Scott, Craig H., Kossev, Plamen M., Kostman, Jay R.

Volltext

Estimating the costs of chemotherapy-associated adverse event clusters von Weiner, Mark G., Ross, Sara J., Mathew, Justin I., Millman, Andrea M., Even-Shoshan, Orit, Fox, Kevin R., Silber, Jeffrey H.

Volltext